Charles K Gayer Biocryst Pharmaceuticals Inc (BCRX) insider trading activity
Charles K Gayer is Chief Commercial Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 423,546 shares of BCRX, which is worth approximately $3.22 Million. The most recent transaction as insider was on Dec 19, 2024, when has been sold 2,461 shares (Common Stock) at a price of $7.39 per share, resulting in proceeds of $18,186. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
424K
37.72%
3M change
54.28%
12M change
Total Value Held
$3.22 Million
Charles K Gayer Transaction History
CKG
Charles K Gayer
Chief Commercial Officer
Durham, NC